Skip to main content
Clinical Trials/NCT03102554
NCT03102554
Enrolling By Invitation
Not Applicable

Utilizing Whole Exome Sequencing and Genomics to Improve Our Understanding of Differences of Sex Development (DSD) and Hypospadias

Boston Children's Hospital1 site in 1 country300 target enrollmentJanuary 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Disorders of Sex Development
Sponsor
Boston Children's Hospital
Enrollment
300
Locations
1
Primary Endpoint
Decision Regret
Status
Enrolling By Invitation
Last Updated
10 months ago

Overview

Brief Summary

This study seeks to identify genetic causes of conditions that affect the gonads and genitals, and to study the impact on families of receiving genetic results.

Detailed Description

This study seeks to understand the genetic causes of conditions that affect the development of the genitals, such as differences of sex development (DSD) and hypospadias, and the impact on families of receiving genetic results. The investigators are recruiting individuals with DSD and/or hypospadias without a clear genetic cause along with their family members for our research study. The investigators will collect samples for genetic studies. The investigators will review the clinical record for history, labs and physical exam information. The investigators will return results of genetic testing to parents/guardians of children with DSD/hypospadias and have them complete questionnaires to assess the impact of receiving these results.

Registry
clinicaltrials.gov
Start Date
January 1, 2018
End Date
December 2026
Last Updated
10 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yee-Ming Chan

Associate Professor of Pediatrics

Boston Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • Genital or gonadal abnormalities as evidenced by physical examination or imaging (including but not limited to hypospadias, microphallus, clitoromegaly, ambiguous genitalia), with no cause identified by standard clinical evaluation

Exclusion Criteria

  • Inability to provide informed consent

Outcomes

Primary Outcomes

Decision Regret

Time Frame: 3 months after return of genetic results

Score on Decision Regret Scale

Secondary Outcomes

  • Stigma(baseline, 3 months after return of genetic results)
  • Anxiety(3 months after return of genetic results compared to baseline)
  • Parenting-Related Stress(3 months after return of genetic results compared to baseline)
  • Child Health-Related Stress(3 months after return of genetic results compared to baseline)
  • Partner Relationship(3 months after return of genetic results compared to baseline)
  • Partner Blame(3 months after return of genetic results compared to baseline)
  • Depression(3 months after return of genetic results compared to baseline)
  • Quality of Life score(baseline, 3 months after return of genetic results)

Study Sites (1)

Loading locations...

Similar Trials